Meltzer HY - Search Results

1

5-HT_2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.

Pogorelov VM, Rodriguiz RM, Cheng J, Huang M, Schmerberg CM, Meltzer HY, Roth BL, Kozikowski AP, Wetsel WC. Pogorelov VM, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2017 Oct;42(11):2163-2177. doi: 10.1038/npp.2017.52. Epub 2017 Mar 15. Neuropsychopharmacology. 2017. PMID: 28294132 Free PMC article.

2

TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA_A receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia.

Rajagopal L, Huang M, Michael E, Kwon S, Meltzer HY. Rajagopal L, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2018 Nov;43(12):2468-2477. doi: 10.1038/s41386-018-0160-3. Epub 2018 Jul 23. Neuropsychopharmacology. 2018. PMID: 30093697 Free PMC article.

3

Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.

Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M. Meltzer HY, et al. Int J Neuropsychopharmacol. 2013 Nov;16(10):2181-94. doi: 10.1017/S1461145713000928. Int J Neuropsychopharmacol. 2013. PMID: 24099265 Free article. Review.

4

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.

Meltzer HY, Roth BL. Meltzer HY, et al. J Clin Invest. 2013 Dec;123(12):4986-91. doi: 10.1172/JCI70678. Epub 2013 Dec 2. J Clin Invest. 2013. PMID: 24292660 Free PMC article. Review.

5

Neurochemical arguments for the use of dopamine D₄ receptor stimulation to improve cognitive impairment associated with schizophrenia.

Huang M, Kwon S, He W, Meltzer HY. Huang M, et al. Among authors: meltzer hy. Pharmacol Biochem Behav. 2017 Jun;157:16-23. doi: 10.1016/j.pbb.2017.04.010. Epub 2017 Apr 25. Pharmacol Biochem Behav. 2017. PMID: 28455126

6

Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.

Huang M, Li Z, Dai J, Shahid M, Wong EH, Meltzer HY. Huang M, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2008 Nov;33(12):2934-45. doi: 10.1038/npp.2008.20. Epub 2008 Apr 16. Neuropsychopharmacology. 2008. PMID: 18418367

7

5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.

Huang M, Horiguchi M, Felix AR, Meltzer HY. Huang M, et al. Among authors: meltzer hy. Neuroreport. 2012 May 9;23(7):436-40. doi: 10.1097/WNR.0b013e328352de40. Neuroreport. 2012. PMID: 22415605

8

Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.

Huang M, Panos JJ, Kwon S, Oyamada Y, Rajagopal L, Meltzer HY. Huang M, et al. Among authors: meltzer hy. J Neurochem. 2014 Mar;128(6):938-49. doi: 10.1111/jnc.12512. Epub 2013 Nov 14. J Neurochem. 2014. PMID: 24164459 Free article.

9

The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia.

Rajagopal L, Massey BW, Huang M, Oyamada Y, Meltzer HY. Rajagopal L, et al. Among authors: meltzer hy. Curr Pharm Des. 2014;20(31):5104-14. doi: 10.2174/1381612819666131216114240. Curr Pharm Des. 2014. PMID: 24345269 Review.

10

RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia.

Rajagopal L, Kwon S, Huang M, Michael E, Bhat L, Cantillon M, Meltzer HY. Rajagopal L, et al. Among authors: meltzer hy. Behav Brain Res. 2017 Aug 14;332:180-199. doi: 10.1016/j.bbr.2017.02.036. Epub 2017 Mar 31. Behav Brain Res. 2017. PMID: 28373127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

959 results

Search Page